HDR monotherapy (2 fractions/13,5 Gy) in LR and favorable IR prostate cancer: analysis of toxicityS. Rodriguez Villalba,P. Monasor Denia,J. Richart Sancho,A. Acosta Rojas,M. J. Perez-Calatayud,J. Perez-Calatayud,M. Santos OrtegaRADIOTHERAPY AND ONCOLOGY(2021)引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要